BUTABARB (BUTABARBITAL SODIUM) — FDA Approval ANDA085873 (ALPHARMA US PHARMS)
BUTABARB (BUTABARBITAL SODIUM) — FDA Approval ANDA085873 (ALPHARMA US PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BUTABARB; Active ingredients: BUTABARBITAL SODIUM; Application number: ANDA085873.
| Brand name | BUTABARB |
|---|---|
| Active ingredients | BUTABARBITAL SODIUM |
| Application number | ANDA085873 |
| Sponsor | ALPHARMA US PHARMS |
| Dosage form | ELIXIR |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19780517 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →